 Meal timing and components, activity levels, and general conditions in the Phase I unit will be as similar as possible on Day -1 and Day 1 of each treatment period. Subjects will be discharged on Day 2 of Period 4 ie, 24 hours after the last dose is administered. The total study duration will be approximately 34 days. 